论文标题
SARS-COV-2传播与ACE2的数学模型适合于年龄和性别的Covid-19杀伤力,并预测SARS的杀伤力,支持可能的治疗
Mathematical model of SARS-Cov-2 propagation versus ACE2 fits COVID-19 lethality across age and sex and predicts that of SARS, supporting possible therapy
论文作者
论文摘要
COVID-19的死亡率随着年龄的增长而升级,男性的死亡率比女性大。我表明,这些变化与大鼠肺中病毒受体蛋白ACE2的水平密切相关,这与仍然有限且显然是矛盾的人类ACE2数据一致。令人惊讶的是,较低的受体水平与较高的死亡相关。然而,先前的数学模型预测,生物体病毒进展的速度具有最大值,然后随着受体水平而下降。此外,许多严重的共证于199的表现,例如严重的肺损伤,加剧的炎症反应和血小板问题可能来自血管紧张素II(ANG-II)水平增加,这是由于病毒降解ACE2而导致的。我在这里提出了一个基于ACE2对病毒传播和疾病严重程度的影响的数学模型。在假设SARS-COV-2感染处于动态状态下,该模型拟合了年龄跨年龄和性别的共同死亡率($ r^2> 0.9 $),在动态状态下,增加受体会减慢病毒传播的速度。此外,通过SARS-COV和SARS-COV-2的尖峰蛋白的结合速率的比率重新缩放模型参数可以预测跨年龄和性别的SARS-COV的死亡率,从而将分子和流行病学水平联系起来。提出的模型反对担心,即血管紧张素受体阻滞剂(ARB)被认为是针对COVID-19的最大不良影响的一种治疗,可能有利于病毒传播,并建议ANG-II和ACE2是候选预后因素,用于检测需要更有需要更强大保护的人群。
The fatality rate of Covid-19 escalates with age and is larger in men than women. I show that these variations correlate strongly with the level of the viral receptor protein ACE2 in rat lungs, which is consistent with the still limited and apparently contradictory data on human ACE2. Surprisingly, lower levels of the receptor correlate with higher fatality. However, a previous mathematical model predicts that the speed of viral progression in the organism has a maximum and then declines with the receptor level. Moreover, many manifestations of severe CoViD-19, such as severe lung injury, exacerbated inflammatory response and thrombotic problems may derive from increased Angiotensin II (Ang-II) level that results from degradation of ACE2 by the virus. I present here a mathematical model based on the influence of ACE2 on viral propagation and disease severity. The model fits Covid-19 fatality rate across age and sex with high accuracy ($r^2>0.9$) under the hypothesis that SARS-CoV-2 infections are in the dynamical regimes in which increased receptor slows down viral propagation. Moreover, rescaling the model parameters by the ratio of the binding rates of the spike proteins of SARS-CoV and SARS-CoV-2 allows predicting the fatality rate of SARS-CoV across age and sex, thus linking the molecular and epidemiological levels. The presented model opposes the fear that angiotensin receptor blockers (ARB), suggested as a therapy against the most adverse effects of CoViD-19, may favour viral propagation, and suggests that Ang-II and ACE2 are candidate prognostic factors for detecting population that needs stronger protection.